StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
24
Publishing Date
2024 - 04 - 24
27
2024 - 04 - 09
26
2024 - 03 - 18
27
2024 - 03 - 05
34
2024 - 02 - 28
30
2024 - 01 - 08
35
2024 - 01 - 04
38
2024 - 01 - 03
30
2024 - 01 - 02
32
2023 - 11 - 13
34
2023 - 11 - 09
47
2023 - 11 - 07
40
2023 - 11 - 06
27
2023 - 11 - 02
37
2023 - 11 - 01
40
2023 - 10 - 31
28
2023 - 10 - 04
27
2023 - 09 - 07
28
2023 - 09 - 06
38
2023 - 09 - 05
49
2023 - 08 - 14
32
2023 - 08 - 10
26
2023 - 08 - 08
28
2023 - 08 - 03
37
2023 - 08 - 02
25
2023 - 08 - 01
25
2023 - 06 - 01
42
2023 - 05 - 31
25
2023 - 05 - 15
30
2023 - 05 - 11
44
2023 - 05 - 10
27
2023 - 05 - 09
31
2023 - 05 - 08
25
2023 - 05 - 04
33
2023 - 05 - 02
32
2023 - 05 - 01
30
2023 - 04 - 27
29
2023 - 03 - 28
26
2023 - 03 - 15
28
2023 - 03 - 09
25
2023 - 03 - 07
27
2023 - 03 - 06
29
2023 - 03 - 01
39
2023 - 02 - 28
25
2023 - 02 - 08
25
2023 - 01 - 09
26
2023 - 01 - 04
25
2022 - 11 - 14
29
2022 - 11 - 10
31
2022 - 11 - 03
35
2022 - 10 - 27
25
2022 - 10 - 26
29
2022 - 09 - 06
28
2022 - 03 - 10
27
2022 - 03 - 08
27
2022 - 03 - 02
26
2022 - 03 - 01
41
2022 - 01 - 05
30
2022 - 01 - 04
33
2021 - 12 - 13
33
Sector
Health technology
17
Manufacturing
2
Process industries
1
Professional, scientific, and technical services
5
Tags
Acquisition
5
Air
7
Als
20
America
12
Application
7
Approval
7
Automotive
4
Biotech-bay
8
Biotechnology
4
Cel
11
Ceo
3
Ces
59
China
4
Commercialization
5
Conference
58
Corporation
12
Covid
7
Covid-19
5
Day
8
Distribution
6
Drug
4
Earnings
11
Ema
5
Energy
11
Europe
9
Events
6
Financial results
40
Food
4
Genetown
7
Group
13
Growing
5
Growth
19
Health
36
Liver
5
Market
4
Milestone
4
N/a
339
Offering
5
One
20
Order
4
Partnership
5
Pharm-country
5
Positive
5
Program
7
Report
66
Research
14
Results
68
Sales
5
Services
9
State
9
Svb leerink global
19
System
11
Technology
8
Test
4
Thc
30
Therapeutics
24
Treatment
5
Trial
10
Vaccine
4
Work
7
Entities
Abbvie inc.
1
Aldeyra therapeutics, inc.
1
Amcor plc
1
Amgen inc.
1
Amicus therapeutics, inc.
1
An2 therapeutics, inc.
1
Applied therapeutics, inc.
1
Astrazeneca plc
1
Chemomab therapeutics ltd - adr
1
Decibel therapeutics inc
1
Denali therapeutics inc.
1
Eli lilly and company
1
Finch therapeutics group inc
1
Nurix therapeutics, inc.
1
Outlook therapeutics, inc.
1
Protagonist therapeutics, inc.
1
Regulus therapeutics inc.
1
Sage therapeutics, inc.
1
Sanofi
2
Transcode therapeutics inc
2
Travere therapeutics inc.
1
Tscan therapeutics inc
1
Vera therapeutics inc - class a
1
Viracta therapeutics inc
1
Vistagen therapeutics, inc.
1
Voyager therapeutics, inc.
1
Symbols
ABBV
1
ALDX
1
AMCR
1
AMGN
1
ANTX
1
APLT
1
AZN
1
AZNCF
1
CMMB
1
DBTX
1
DNLI
1
FNCH
1
FOLD
1
LLY
1
NRIX
1
OTLK
1
PTGX
1
RGLS
1
RNAZ
2
SAGE
1
SNY
2
SNYNF
2
TCRX
1
TVTX
1
VERA
1
VIRX
1
VTGN
1
VYGR
1
Exchanges
Nasdaq
22
Nyse
3
Crawled Date
2022 - 02 - 12
1
2022 - 02 - 11
1
2022 - 02 - 10
22
Crawled Time
00:00
1
12:30
5
13:30
5
14:00
2
15:00
1
16:20
1
17:00
1
20:00
2
21:00
1
22:00
3
23:00
2
Source
ir.voyagertherapeutics.com
1
www.biospace.com
12
www.globenewswire.com
8
www.prnewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2022 - 02 - 10
tags :
Therapeutics
save search
Voyager Therapeutics to Participate in Upcoming Investor Conferences
Published:
2022-02-10
(Crawled : 16:20)
- ir.voyagertherapeutics.com
VYGR
|
News
|
$7.57
-1.05%
-1.06%
310K
|
Health Technology
|
117.53%
|
O:
-0.57%
H:
0.58%
C:
-3.47%
conference
therapeutics
Nurix Therapeutics Announces Participation in the 11th Annual SVB Leerink Global Healthcare Conference
Published:
2022-02-10
(Crawled : 00:00)
- biospace.com/
NRIX
6 d
|
$13.73
-2.83%
-2.91%
520K
|
Health Technology
|
-30.17%
|
O:
-4.77%
H:
0.0%
C:
0.0%
health
ces
thc
conference
therapeutics
svb leerink global
VistaGen Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update
Published:
2022-02-10
(Crawled : 23:00)
- biospace.com/
VTGN
|
$4.75
-1.66%
-1.68%
150K
|
Health Technology
|
191.36%
|
O:
-2.47%
H:
5.06%
C:
-2.53%
financial results
therapeutics
report
results
AN2 Therapeutics Reports Phase 1b Data for Oral Epetraborole
Published:
2022-02-10
(Crawled : 23:00)
- biospace.com/
ANTX
|
$2.42
2.11%
2.07%
45K
|
|
Email alert
Add to watchlist
phase 1b
therapeutics
phase 1
report
phase 2b
Regulus Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
Published:
2022-02-10
(Crawled : 22:00)
- prnewswire.com
RGLS
|
$2.23
-1.33%
-1.35%
92K
|
Health Technology
|
772.64%
|
O:
2.2%
H:
0.08%
C:
-3.81%
health
thc
conference
therapeutics
svb leerink global
Decibel Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
Published:
2022-02-10
(Crawled : 22:00)
- globenewswire.com
DBTX
|
$4.91
-0.81%
-0.2%
0
|
Health Technology
|
20.05%
|
O:
-0.24%
H:
0.8%
C:
-5.39%
health
thc
conference
therapeutics
svb leerink global
Travere Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results
Published:
2022-02-10
(Crawled : 22:00)
- globenewswire.com
TVTX
|
$5.46
-4.88%
-5.13%
2M
|
Health Technology
|
-80.12%
|
O:
0.58%
H:
2.86%
C:
1.41%
financial results
therapeutics
report
results
Viracta Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
Published:
2022-02-10
(Crawled : 21:00)
- biospace.com/
VIRX
|
$0.8367
-1.31%
-1.33%
55K
|
Manufacturing
|
-71.62%
|
O:
4.05%
H:
7.13%
C:
4.87%
health
thc
conference
therapeutics
svb leerink global
Aldeyra Therapeutics to Participate in Fireside Chat at the SVB Leerink 2022 Global Healthcare Conference
Published:
2022-02-10
(Crawled : 20:00)
- biospace.com/
ALDX
|
$3.93
0.51%
0.51%
570K
|
Health Technology
|
-2.96%
|
O:
-3.2%
H:
9.03%
C:
1.27%
health
thc
conference
therapeutics
Healis Therapeutics acquires ownership of key botulinum toxin patent
Published:
2022-02-10
(Crawled : 20:00)
- biospace.com/
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
16.63%
|
O:
-0.5%
H:
0.89%
C:
-0.31%
xin
patent
therapeutics
Stroke Therapeutics Market to register a growth of USD 1.54 billion at a CAGR of 5% | High-risk Factors for Stroke is a Key Driver | Technavio
Published:
2022-02-10
(Crawled : 17:00)
- prnewswire.com
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
18.19%
|
O:
-0.35%
H:
4.64%
C:
1.43%
AMCR
|
$9.06
0.89%
0.0%
5.8M
|
Process Industries
|
-22.63%
|
O:
0.09%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-11.1%
|
O:
-0.92%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
25.0%
|
O:
2.11%
H:
3.46%
C:
0.76%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
13.36%
|
O:
-2.42%
H:
0.49%
C:
-2.63%
risk
therapeutics
stroke
growth
CORRECTION --TransCode Therapeutics
Published:
2022-02-10
(Crawled : 15:00)
- globenewswire.com
RNAZ
|
$0.452
-1.72%
-1.75%
91K
|
Professional, Scientific, and T...
|
-99.09%
|
O:
4.55%
H:
0.0%
C:
-7.11%
therapeutics
Chemomab Therapeutics to Present at Aegis Virtual Conference
Published:
2022-02-10
(Crawled : 14:00)
- biospace.com/
CMMB
|
$0.67
0.02%
3.4K
|
Manufacturing
|
-85.26%
|
O:
4.51%
H:
4.63%
C:
-1.68%
conference
therapeutics
Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock
Published:
2022-02-10
(Crawled : 14:00)
- globenewswire.com
VERA
|
$39.94
1.06%
1.05%
770K
|
Professional, Scientific, and T...
|
89.88%
|
O:
-10.98%
H:
1.07%
C:
-4.97%
offering
ces
therapeutics
TransCode Therapeutics to Present at 2020 BIO CEO & INVESTOR CONFERENCE
Published:
2022-02-10
(Crawled : 13:30)
- globenewswire.com
RNAZ
|
$0.452
-1.72%
-1.75%
91K
|
Professional, Scientific, and T...
|
-99.09%
|
O:
4.55%
H:
0.0%
C:
-7.11%
ceo
conference
therapeutics
Finch Therapeutics Announces Additions to Senior Leadership Team
Published:
2022-02-10
(Crawled : 13:30)
- biospace.com/
FNCH
|
$2.305
-17.35%
-20.99%
120K
|
Professional, Scientific, and T...
|
-73.07%
|
O:
5.5%
H:
1.55%
C:
-5.22%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-11.1%
|
O:
-0.92%
H:
0.0%
C:
0.0%
therapeutics
Amicus Therapeutics to Announce Full-Year 2021 Financial Results on February 24, 2022
Published:
2022-02-10
(Crawled : 13:30)
- biospace.com/
FOLD
4
|
$10.52
-1.77%
-1.81%
1.6M
|
Health Technology
|
14.44%
|
O:
0.33%
H:
3.63%
C:
-0.97%
financial results
therapeutics
results
Denali Therapeutics Announces Continued Progress in DNL310 (ETV:IDS) Program for MPS II (Hunter Syndrome) Supporting Planned Initiation of Phase 2/3 Clinical Trial
Published:
2022-02-10
(Crawled : 13:30)
- biospace.com/
DNLI
|
$15.55
-3.48%
-3.6%
940K
|
Health Technology
|
-57.82%
|
O:
1.08%
H:
3.35%
C:
-2.74%
dnl310
phase 2
phase 2/3
program
trial
therapeutics
syndros
mps-ih
Outlook Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
Published:
2022-02-10
(Crawled : 13:30)
- globenewswire.com
OTLK
|
News
P
|
$8.2
0.0%
240K
|
Health Technology
|
502.94%
|
O:
-0.74%
H:
5.93%
C:
2.22%
health
thc
conference
therapeutics
svb leerink global
Arkuda Therapeutics Raises $64 Million Series B Financing to Advance Pipeline of Programs Targeting Lysosomal Biology to Treat Neurodegenerative Diseases
Published:
2022-02-10
(Crawled : 12:30)
- biospace.com/
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
211.62%
|
O:
-0.69%
H:
0.0%
C:
0.0%
program
therapeutics
disease
neurodegenerative
← Previous
1
2
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.